What is important is what the CEO will NOT say, but what he and they WILL say. US buyers will think this is one of the cheapest Biotech stock and continue to buy at these cheap levels. Incl. Convertible holding, US investors total holding is building up quite nicely.
Would expect further buying tomorrow afternoon, followed by RNS Wednesday or even better on Thursday AM.Significant Revaluation of the AVA pipeline to be expected.
With ASCO Genitourinary Symposium taking place in San Fran. Right now and with Novartis,Bayer,Gilead Science and Merck speaking, would expect more Precision oncology stories to be circulating in front of Science day.
Size buyers knocking on the door, carrying a Bagel and Latte, watch early NY trade and we will have size buyers lifting the price 175-80 and then Science day week and RNS and everybody will be smiling by Thursday.